Dr. Zemskova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NIH Clinical Center
10 Center Dr
Bethesda, MD 20892
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2022 - 2024
George Washington UniversityInternship, Internal Medicine, 2019 - 2022
The University of Toledo College of MedicineClass of 2019
Certifications & Licensure
DC State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults Start of enrollment: 2023 Aug 04
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) Start of enrollment: 2024 Jun 26
Publications & Presentations
PubMed
- 5 citationsHIV treatment with dolutegravir and doravirine: rationale for selection and clinical outcomes in a highly treatment experienced population.Rachel Denyer, Julie Zemskova, Debra A Benator
International Journal of STD & AIDS. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
